NT$ 129.5
Key Takeaways
Risk factor
Weak & very vulnerable to price shocks
Data is available to registered users only
Data is available to registered users only
Profitability factor
Favourable price performance
Data is available to registered users only
Data is available to registered users only
About
ACRO Biomedical Co., Ltd. is dedicated to the creation and manufacturing of biomaterial-based medical devices, specifically designed for applications in human tissue engineering and regenerative medicine. This company was established on June 26, 2014, and operates primarily from its headquarters in Kaohsiung, Taiwan.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Data is available to registered users only